Status:
UNKNOWN
Clinical Research on Shenfu Injection in Septic Patients
Lead Sponsor:
Ruijin Hospital
Collaborating Sponsors:
Wu Jieping Medical Foundation
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sepsis, characterized by organ dysfunction caused by infection, exhibits increasing incidence and mortality rates, posing a significant challenge to intensive care units. Early-stage sepsis involves h...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Signed informed consent form;
- Meets sepsis 3.0 diagnostic criteria;
Exclusion
- Age \< 18 years;
- Known pregnancy;
- Inability to accept and complete signed informed consent within 24 hours of diagnosis of sepsis;
- Status of tracheal intubation;
- oral mucosal inflammation or damage;
- Patients with contraindications to transcutaneous oxygen partial pressure testing such as severe edema and burns;
- Concurrent participation in other treatment studies.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06157320
Start Date
December 1 2023
End Date
January 1 2026
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, Shanghai Municipality, China, 200025